(NYSE: AORT) Artivion's forecast annual revenue growth rate of 11.81% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.92%.
Artivion's revenue in 2025 is $390,084,000.On average, 2 Wall Street analysts forecast AORT's revenue for 2025 to be $18,746,522,615, with the lowest AORT revenue forecast at $18,746,522,615, and the highest AORT revenue forecast at $18,746,522,615. On average, 2 Wall Street analysts forecast AORT's revenue for 2026 to be $20,738,607,535, with the lowest AORT revenue forecast at $20,672,418,219, and the highest AORT revenue forecast at $20,804,796,852.
In 2027, AORT is forecast to generate $23,029,611,951 in revenue, with the lowest revenue forecast at $23,029,611,951 and the highest revenue forecast at $23,029,611,951.